Riskpilot← Back to searchSign inGet full accessMEDEQUIP ApS
APSActiveCVR 20602430Søvang 8Wholesale of pharmaceutical and medical goods · NACE 4646Est. 1998— employees
Revenue 2024
DKK 138K
+12% vs 2023
EBITDA margin
100.0%
+12% vs 2023
Equity ratio
59.9%
Financial strength
Net profit 2024
DKK 121K
+4% vs 2023
| Revenue | DKK 138K | +12% |
| EBITDA | DKK 138K | +12% |
| Net profit | DKK 121K | +4% |
| Total assets | DKK 2,1M | -6% |
| Equity | DKK 1,3M | +10% |
| Employees | — | — |
Legal name
MEDEQUIP ApS
CVR number
20602430
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. januar 1998
Share capital
DKK 125.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive handel og industri samt anden dermed beslægtet virksomhed
Address
Søvang 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 594 | 243 | 1.391 | 559 | 1.099 | 24 | -118 | -447 | 124 | 138 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -88 | -88 | -90 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -1 | 0 | 0 | 594 | 243 | 1.303 | 471 | 1.009 | 1.341 | -118 | -447 | 124 | 138 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -1 | 0 | 0 | 594 | 243 | 1.303 | 471 | 1.009 | 1.341 | -118 | -447 | 124 | 138 |
| Net financials | 0 | 0 | 0 | -0 | 15 | -70 | -65 | 90 | -2.664 | 35 | -44 | -58 | -3 |
| Profit before tax | -1 | 0 | 0 | 594 | 258 | 1.233 | 406 | 1.099 | -1.323 | -83 | -491 | 65 | 136 |
| Tax | -0 | -0 | -0 | 20 | 32 | 280 | 93 | -0 | 17 | -194 | -196 | -50 | 15 |
| Net profit | -1 | 0 | 0 | 573 | 226 | 953 | 313 | 1.099 | -1.341 | 111 | -296 | 116 | 121 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.100 | 2.100 | 2.100 | 2.706 | 3.121 | 3.958 | 3.890 | 4.337 | 4.373 | 3.599 | 3.708 | 2.264 | 2.134 |
| Equity | -280 | -280 | -280 | 293 | 519 | 1.368 | 1.576 | 2.567 | 1.226 | 1.337 | 1.042 | 1.157 | 1.278 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.456 | 0 | 0 |
| Short-term debt | 2.380 | 2.380 | 2.380 | 2.392 | 2.550 | 2.257 | 1.952 | 1.408 | 2.709 | 2.018 | 1.163 | 1.107 | 844 |
| Total debt | 2.380 | 2.380 | 2.380 | 2.392 | 2.550 | 2.257 | 1.952 | 1.408 | 2.709 | 2.018 | 2.619 | 1.107 | 844 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
59.9%
This company
38.2%
Market median
+57% vs market
20122024
Return on equity
9.4%
This company
18.4%
Market median
-49% vs market
20122024
Net profit margin
87.0%
This company
8.1%
Market median
+974% vs market
20122024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20122024
Debt / equity
0.67×
This company
0.62×
Market median
+8% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JB Management | Management | 1998 | — | — |
SS Management | Management | 1998 | — | — |
EJ Management | Management | 1998 | — | — |
KB Audit | Audit | 1998 | — | — |
AK Management | Management | 2007 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDEQUIP ApS (this company)
ARTEK ApSBoard members of MEDEQUIP ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Bo Hvidt | Management | 0 companies |
| Steen Schierbeck | Management | 0 companies |
| Erik Johansen | Management | 0 companies |
| Kurt Bülow | Audit | 0 companies |
| Allan Kylén Nørager | Management | 0 companies |